{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:26:52Z","timestamp":1772825212598,"version":"3.50.1"},"reference-count":34,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2019,2,1]]},"DOI":"10.1080\/13696998.2018.1548355","type":"journal-article","created":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T08:08:52Z","timestamp":1542182932000},"page":"131-139","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":16,"title":["Evaluating the cost-effectiveness of percutaneous closure of a patent foramen ovale versus medical management in patients with a cryptogenic stroke: from the UK payer perspective"],"prefix":"10.1080","volume":"22","author":[{"given":"David","family":"Hildick-Smith","sequence":"first","affiliation":[{"name":"The Sussex Cardiac Centre, Brighton & Sussex University Hospital NHS Trust, Brighton, UK;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Turner","sequence":"additional","affiliation":[{"name":"The Bristol Heart Institute, University Hospitals Bristol NHS Foundation Trust, Bristol, UK;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Shaw","sequence":"additional","affiliation":[{"name":"Royal United Hospitals Bath NHS Foundation Trust, Bath, UK;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitesh","family":"Nakum","sequence":"additional","affiliation":[{"name":"Curo, Envision Pharma Group, Marlow, UK;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Br\u00edain \u00d3","family":"Hartaigh","sequence":"additional","affiliation":[{"name":"Curo, Envision Pharma Group, Southport, CT, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard M.","family":"Evans","sequence":"additional","affiliation":[{"name":"W.L. Gore & Associates Inc., Livingston, UK;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F.","family":"Rhodes","sequence":"additional","affiliation":[{"name":"The Congenital Heart Center, Medical University of South Carolina, Charleston, SC, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Sondergaard","sequence":"additional","affiliation":[{"name":"The Heart Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott E.","family":"Kasner","sequence":"additional","affiliation":[{"name":"University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2018,11,29]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.02.017"},{"key":"CIT0002","volume-title":"Scottish Stroke Improvement Programme Report 2017","author":"National Services Scotland (NHS)","year":"2017"},{"key":"CIT0003","volume-title":"National clinical audit annual results portfolio April 2016\u2013March 2017","author":"Sentinel Stroke National Audit Programme (SSNAP)","year":"2017"},{"key":"CIT0004","volume-title":"Vital events. Deaths by sex, age and cause, Scotland, 2015","author":"National Records of Scotland (NRS)","year":"2016"},{"key":"CIT0005","volume-title":"Registrar General Annual Report 2015 deaths by cause tables","author":"Northern Ireland Statistics and Research Agency (NISRA)","year":"2016"},{"key":"CIT0006","volume-title":"Heart attack and stroke: men vs. women","author":"Harvard Medical School","year":"2014"},{"key":"CIT0007","unstructured":"World Health Organization. Global Health Observatory data repository; 2018. Available at: http:\/\/apps.who.int\/gho\/data\/view.main.LT62260?lang=en [Last accessed September 28, 2018]"},{"key":"CIT0008","first-page":"CD009938","volume":"9","author":"Li J","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1234146"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.02.046"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1705915"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1610057"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707404"},{"key":"CIT0014","doi-asserted-by":"crossref","unstructured":"Leppert MH, Poisson SN, Carroll JD, et\u00a0al. Cost-effectiveness of patent foramen ovale closure versus medical therapy for secondary stroke prevention. Stroke 2018;49:1443\u201350","DOI":"10.1161\/STROKEAHA.117.020322"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2014.08.027"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2018.1456445"},{"key":"CIT0017","volume-title":"Current, future, and avoidable costs of stroke in the UK. Executive summary Part 2: Societal costs of stroke in the next 20 years and potential returns from increased spending on research","author":"Patel A","year":"2017"},{"key":"CIT0018","volume-title":"England and Wales. Electronic drug tariff","author":"National Health Service (NHS)","year":"2018"},{"key":"CIT0019","volume-title":"British National Formulary","author":"National Institute for Health and Care Excellence (NICE)","year":"2017"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200321030-00004"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1412981"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.32.6.1425"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182a9f45f"},{"key":"CIT0024","unstructured":"York Health Economics Consortium (YHEC), Willitis I, Keltie K, et\u00a0al. NICE Observational Data Unit (ODU): commissioning through evaluation (CtE) percutaneous closure of patent foramen ovale (PFOC) to prevent recurrent cerebral embolic events. Final report. Newcastle upon Tyne: Newcastle and York External Assessment Centre (NY EAC), York Health Economics Consortium; 2018. Available at: https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2018\/07\/patent-foramen-ovale-closure-evaluation-report.pdf [Last accessed October 2, 2018]"},{"key":"CIT0025","doi-asserted-by":"crossref","unstructured":"Luengo-Fernandez R, Gray AM, Rothwell PM. A population-based study of hospital care costs during 5 years after transient ischemic attack and stroke. Stroke 2012;43:3343\u201351","DOI":"10.1161\/STROKEAHA.112.667204"},{"key":"CIT0026","unstructured":"NHS England. Commissioning through Evaluation program; 2015. Available at: https:\/\/www.england.nhs.uk\/commissioning\/spec-services\/npc-crg\/comm-eval [Last accessed September 28, 2018]"},{"key":"CIT0027","unstructured":"NHS PSSRU. Unit Costs of Health and Social Care 2017. Available at: https:\/\/www.pssru.ac.uk\/project-pages\/unit-costs\/unit-costs-2017\/ [Last accessed September 28, 2018]"},{"key":"CIT0028","unstructured":"National Institute for Health and Care Excellence. The guidelines manual; 2012. Available at: https:\/\/www.nice.org.uk\/process\/pmg6\/chapter\/assessing-cost-effectiveness [Last accessed September 28, 2018]"},{"key":"CIT0029","volume-title":"Improvement. Reference costs, 2016\/17","author":"National Health Service (NHS)","year":"2017"},{"key":"CIT0030","volume-title":"State of the nation: Stroke statistics February","author":"Stroke Association","year":"2018"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000817"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1177\/1747493017701152"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000017498.88393.44"},{"key":"CIT0034","volume-title":"for Cardiac Services. Clinical commissioning policy: left atrial appendage occlusion for patients with atrial fibrillation and relative or absolute contraindications to anticoagulation (adults","author":"NHS England Specialised Services Clinical Reference Group","year":"2018"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2018.1548355","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T22:09:43Z","timestamp":1599430183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2018.1548355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,29]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2,1]]}},"alternative-id":["10.1080\/13696998.2018.1548355"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2018.1548355","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,29]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-10-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-05","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}